General Biologicals 

TWD5.59
0
-TWD0.63-10.13% 06:57 Today

Statistics

Day High
6.14
Day Low
5.32
52W High
15.4
52W Low
4.15
Volume
257,657
Avg. Volume
132,389
Mkt Cap
395.91M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

215.93%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
215.74MRevenue
465.84MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

General Biologicals Corporation (GBC) is a company dedicated to the research, development, production, and global commercialization of in-vitro diagnostic (IVD) solutions, operating extensively both within Taiwan and internationally. The company's core diagnostic offerings include advanced ELISA and chemiluminescence immunoassays, molecular and cellular diagnostic platforms, and rapid point-of-care testing (POCT) systems. Its diverse portfolio further encompasses COVID-19 related solutions, digital pathology, and contract development manufacturing organization (CDMO) services. Additionally, GBC provides essential blood screening services for detecting hepatitis and HIV, alongside crucial biomaterials such as antibody preparations and human plasma. Venturing beyond diagnostics, the company also markets a line of oral care products under its proprietary 'oh care' brand. These diagnostic systems are primarily utilized by clinics and laboratories. Founded in 1973, General Biologicals Corporation is headquartered in Hsinchu City, Taiwan.
Show More
CEO
Frank Lin
Employees
200
Country
Taiwan
ISIN
TW0004117007

Listings

0 Comments

Share your thoughts

FAQs

What is General Biologicals stock price today?▼
The current price of 4117.TWO is TWD5.59 TWD — it has decreased by -10.13% in the past 24 hours. Watch General Biologicals stock price performance more closely on the chart.
What is General Biologicals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange General Biologicals stocks are traded under the ticker 4117.TWO.
Is General Biologicals stock price growing?▼
4117.TWO stock has fallen by -20.14% compared to the previous week, the month change is a -34.24% fall, over the last year General Biologicals has showed a -63.58% decrease.
What is General Biologicals market cap?▼
Today General Biologicals has the market capitalization of 395.91M
What is General Biologicals revenue for the last year?▼
General Biologicals revenue for the last year amounts to 215.74M TWD.
What is General Biologicals net income for the last year?▼
4117.TWO net income for the last year is 465.84M TWD.
How many employees does General Biologicals have?▼
As of November 3, 2026, the company has 200 employees.
In which sector is General Biologicals located?▼
General Biologicals operates in the Health & Wellness sector.
When did General Biologicals complete a stock split?▼
General Biologicals has not had any recent stock splits.
Where is General Biologicals headquartered?▼
General Biologicals is headquartered in Hsinchu City, Taiwan.